Product image of Linezolid Kabi (Linezolid) supplied by GNH India

Linezolid Kabi

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Kabi (Linezolid)

Linezolid, the active ingredient in Linezolid Kabi, is an oxazolidinone presented as an injection for intravenous use. It treats serious bacterial infections such as complicated skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, and infections caused by MRSA or VRE in adult patients.
GNH India supplies Linezolid Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Fresenius Kabi Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibacterial indicated for several serious infections.

  • Complicated skin and soft tissue infections: provides bactericidal activity against susceptible Gram‑positive pathogens, facilitating recovery.
  • Community‑acquired pneumonia: treats pneumonia caused by susceptible organisms, improving respiratory function.
  • Nosocomial pneumonia: effective against hospital‑acquired respiratory infections, reducing morbidity.
  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: offers an alternative to vancomycin for resistant strains.
  • Vancomycin‑resistant Enterococcus (VRE) infections: active against resistant enterococci where other options are limited.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks the translation step of protein production, leading to a bacteriostatic effect against susceptible Gram‑positive organisms.

Side Effects

Adverse reactions may occur with linezolid therapy.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Rash: skin erythema or pruritus.
  • Metallic taste: altered taste perception.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Anemia: reduced red blood cell levels.
  • Peripheral neuropathy: nerve damage presenting as tingling or numbness.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: rare metabolic disturbance.
  • Optic neuropathy: vision changes that may be irreversible.

Precautions & Warnings

Use linezolid with careful clinical monitoring.

  • Renal impairment: assess renal function and monitor for accumulation.
  • Hepatic dysfunction: evaluate liver enzymes regularly.
  • Concomitant serotonergic agents: avoid due to risk of serotonin syndrome.
  • Prolonged therapy: perform routine blood‑count surveillance.
  • Pregnancy and lactation: safety not established; weigh benefits against risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Linezolid may interact with several drug classes.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): heightened serotonin toxicity.
  • Tricyclic antidepressants: additive serotonergic effect.

Moderate Interactions (Monitor Closely)

  • Rifampin: induces metabolism, reducing linezolid exposure.
  • Warfarin: may increase INR, requiring coagulation monitoring.
  • Anticonvulsants (e.g., carbamazepine): may lower linezolid concentrations.

Frequently Asked Questions

Linezolid Kabi is indicated for serious Gram‑positive bacterial infections such as complicated skin and soft‑tissue infections, community‑acquired and hospital‑acquired pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) or vancomycin‑resistant Enterococcus (VRE).

Linezolid binds to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth, providing a bacteriostatic effect against susceptible organisms.

The dosage and duration of Linezolid Kabi are determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local guidelines. No fixed regimen is provided here.

Safety data for linezolid in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the treating physician.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Both linezolid and vancomycin target Gram‑positive bacteria, but linezolid is an oral and intravenous oxazolidinone with activity against MRSA and VRE, while vancomycin is a glycopeptide primarily given intravenously. Linezolid offers a convenient IV-to‑oral switch and does not require therapeutic drug monitoring, but it carries a different safety profile, including risk of thrombocytopenia and serotonin syndrome.

Linezolid Kabi should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Maintain the cold‑chain during transport and store in the original packaging until use.

Linezolid Kabi is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional according to the prescribed infusion rate and duration, typically over a period of 30‑60 minutes, depending on clinical protocol.

Serious adverse events include thrombocytopenia, anemia, peripheral neuropathy, optic neuropathy, serotonin syndrome when combined with serotonergic drugs, and rare metabolic disturbances such as lactic acidosis. Patients should be monitored regularly for hematologic and neurologic changes.

Linezolid Kabi is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. Caution is advised for individuals taking serotonergic agents, those with uncontrolled hypertension, and patients with severe hepatic or renal impairment where benefits may not outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT